EFFICACY AND SAFETY OF TOFACITINIB AFTER FAILURE OF ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A US-BASED PROPENSITY MATCHED COHORT STUDY

被引：0
|
作者：
Kochhar, Gursimran S.
Desai, Aakash
Dulai, Parambir S.
Cross, Raymond K.
Farraye, Francis A.
Regueiro, Miguel D.
El-Hachem, Sandra
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1711
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
  • [21] Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 23
  • [22] Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure
    Judge, C.
    McGettigan, N.
    Ryan, T.
    Hazel, K.
    Singh, P.
    Parihar, V.
    Stack, R.
    O'Connor, A.
    Dunne, C.
    Cullen, G.
    Egan, L.
    Harewood, G.
    MacCarthy, F.
    McKiernan, S.
    Mulcahy, H.
    Murray, F.
    Patchett, S.
    Sheridan, J.
    Trevian, D.
    Breslin, N.
    Farrell, R.
    Keohane, J.
    Kelly, O.
    McNamara, D.
    Ryan, B.
    Smyth, C.
    O'Morain, C.
    Sengupta, S.
    Slattery, E.
    Doherty, G.
    Kevans, D.
    O'Toole, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S410 - S411
  • [23] Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent
    Buisson, Anthony
    Nachury, Maria
    Guilmoteau, Thomas
    Altwegg, Romain
    Treton, Xavier
    Fumery, Mathurin
    Serrero, Melanie
    Leclerc, Eloise
    Caillo, Ludovic
    Pereira, Bruno
    Amiot, Aurelien
    Bouguen, Guillaume
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 676 - 688
  • [24] Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study
    Nawaz, Ahmad
    Almasaid, Sharifeh
    Shah, Ayushi
    Hussain, Azhar
    Chaar, Abdelkader
    Patel, Shanti
    Khalid, Fatima
    Hayat, Umar
    Singh, Kelita
    Aswath, Ganesh
    Khan, Hafiz Muzaffar Akbar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S1011 - S1012
  • [25] Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Anti-TNF Experienced Patients with Ulcerative Colitis: A Retrospective Study
    Sror, N.
    Leibovitzh, H.
    Hirsch, A.
    Thurm, T.
    Ron, Y.
    Maharshak, N.
    Cohen, N. A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1573 - i1574
  • [26] Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study
    Nazari, Mohammad Hossein Derakhshan
    Shahrokh, Shabnam
    Ghanbari-Maman, Leila
    Maleknia, Samaneh
    Ghorbaninejad, Mahsa
    Meyfour, Anna
    HELIYON, 2023, 9 (11)
  • [27] Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
    Emily C. L. Wong
    Shahin Merat
    Cristina Monaco
    Parambir S. Dulai
    Vipul Jairath
    John K. Marshall
    Walter Reinisch
    Neeraj Narula
    Digestive Diseases and Sciences, 2023, 68 : 2635 - 2646
  • [28] Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study
    Kochhar, Gursimran S.
    Desai, Aakash
    Farraye, Francis A.
    Cross, Raymond K.
    El-Hachem, Sandra
    Dulai, Parambir S.
    Regueiro, Miguel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (03) : 297 - 308
  • [29] Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
    Wong, Emily C. L.
    Merat, Shahin
    Monaco, Cristina
    Dulai, Parambir S.
    Jairath, Vipul
    Marshall, John K.
    Reinisch, Walter
    Narula, Neeraj
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2635 - 2646
  • [30] Efficacy of Turmeric (Curcumin) Plus Mesalamine in Ulcerative Colitis: A Propensity-Matched Cohort Study
    Khataniar, Himsikhar
    Tabaku, Fjona
    Muzammil, Taimur S.
    Hashash, Jana G.
    Farraye, Francis A.
    Kochhar, Gursimran S.
    Desai, Aakash
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S786 - S787
12345